Pacira BioSciences Management
Management criteria checks 2/4
Pacira BioSciences' CEO is Frank Lee, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.018% of the company’s shares, worth $138.27K. The average tenure of the management team and the board of directors is 2.5 years and 5.2 years respectively.
Key information
Frank Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.02% |
| Management average tenure | 2.5yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Pacira BioSciences, Inc. (NASDAQ:PCRX) Not Doing Enough For Some Investors As Its Shares Slump 34%
Sep 06
Little Excitement Around Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Revenues As Shares Take 29% Pounding
Jul 23These 4 Measures Indicate That Pacira BioSciences (NASDAQ:PCRX) Is Using Debt Safely
Jun 07Pacira BioSciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
May 10Getting In Cheap On Pacira BioSciences, Inc. (NASDAQ:PCRX) Might Be Difficult
May 03Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?
Feb 05Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Low P/S No Reason For Excitement
Jan 05We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt
Nov 03Is Pacira BioSciences (NASDAQ:PCRX) Using Too Much Debt?
Jul 28Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Intrinsic Value Is Potentially 26% Below Its Share Price
Jul 07Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?
Apr 18We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt
Dec 28Assessing Pacira BioSciences' Growth Prospects
Oct 20Pacira BioSciences guides Q3 revenue below consensus
Oct 13Pacira, Sevāredent team up to expand access to pain drug Exparel for dental procedures
Sep 27EMA panel backs expanding indication for Pacira's postsurgical pain treatment in kids
Sep 20Pacira BioSciences records 17.7% sequential growth in August revenue
Sep 13Pacira BioSciences provides update on July product sales
Aug 10Pacira BioSciences Q2 2022 Earnings Preview
Aug 02Pacira BioSciences sees Q2 revenue below consensus
Jul 14CEO
Frank Lee (56 yo)
less than a year
Tenure
Mr. Frank D. Lee served as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021 until September 2024. He is Independent Director of Bausch Health Companies Inc. from May 14, 2024. He i...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Operating Officer | 2.5yrs | US$1.53m | 0.027% $ 204.9k | |
| Chief Administrative Officer & Secretary | 10.1yrs | US$1.60m | 0% $ 0 | |
| Advisor | less than a year | US$6.88m | 0.51% $ 4.0m | |
| Executive Officer | less than a year | US$1.43m | 0.059% $ 458.8k | |
| Chief Medical Officer | 3.3yrs | US$1.59m | 0.028% $ 217.1k | |
| CEO & Director | less than a year | no data | 0.018% $ 138.3k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Principal Accounting Officer & Senior VP of Finance | 12.7yrs | US$288.82k | 0.0046% $ 35.8k | |
| Head of Investor Relations | no data | no data | no data | |
| Chief Legal & Compliance Officer | 2.9yrs | US$2.05m | 0.028% $ 215.4k | |
| Vice President of Human Resources | 9.3yrs | no data | no data | |
| Chief Manufacturing Officer | 1.6yrs | no data | no data |
2.5yrs
Average Tenure
54yo
Average Age
Experienced Management: PCRX's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | 0.018% $ 138.3k | |
| Independent Director | 13.4yrs | US$364.01k | 0.027% $ 206.2k | |
| Chairman of the Board | 13.4yrs | US$390.51k | 0.016% $ 125.4k | |
| Independent Director | 17.9yrs | no data | no data | |
| Independent Director | 11.4yrs | US$373.01k | 0.043% $ 329.1k | |
| Independent Director | 5.2yrs | US$325.01k | 0.011% $ 88.0k | |
| Independent Director | 1.1yrs | US$427.86k | 0% $ 0 | |
| Independent Director | 1.1yrs | US$426.45k | 0.011% $ 82.2k | |
| Independent Director | 1.1yrs | US$427.16k | 0% $ 0 | |
| Independent Director | 7.4yrs | US$349.01k | 0.020% $ 154.7k | |
| Independent Director | 1.1yrs | US$427.16k | 0.0043% $ 33.4k |
5.2yrs
Average Tenure
62.5yo
Average Age
Experienced Board: PCRX's board of directors are considered experienced (5.2 years average tenure).